| News

Swiss TPH breaks ground on new headquarters

24.06.2019

The Swiss Tropical and Public Health institute (Swiss TPH) has broken ground on the new building for its headquarters in Allschwil. Set for completion by the end of 2021, the new building will offer nearly 900 workplaces, laboratory spaces as well as teaching facilities.

Visualization of the new building "Belo Horizonte" (img. Joachim Pelikan / Swiss TPH)

Swiss TPH is currently spread across seven buildings in Basel, but by the end of 2021 its employees and students will be able to work, conduct research and study under one roof, according to a press release. The new headquarters in Allschwil in the canton of Basel-Landschaft will have a floor space of 13,376 square metres and offer 725 workplaces, over 150 laboratory spaces, as well as auditoriums, classrooms and a cafeteria.

The groundbreaking ceremony for the new multifunctional building, called Belo Horizonte, was held on Friday. Guests included Monica Gschwind, President of the Government Council of Basel-Landschaft; Conradin Cramer, Member of the Government of the Canton of Basel-Stadt; Marcel Tanner, President of the R. Geigy Foundation; and Andrea Schenker-Wicki, Rector of the University of Basel.

“We are very much looking forward to our new home in Allschwil,” said Jürg Utzinger, Director of Swiss TPH. “The new building brings together work, laboratory and education spaces in a unique way that will enable us to even better fulfil our mandate to improve the health of people in the Basel region, Switzerland and worldwide.” Stefan Mörgeli, project manager for the new building, said: “We only came to Allschwil because there is the political will to build the new Switzerland Innovation Park Basel Area here.”

The new building is a part of the BaseLink area of the Bürgerspital Basel hospital. It will cost some 90 million Swiss francs, with funding provided by a credit guarantee from the cantons of Basel-Landschaft and Basel-Stadt, investment contributions from the Swiss government, Swiss TPH’s own funds, and support from the R. Geigy Foundation. Swiss TPH plans to move into the building at the end of 2021. Founded in 1943, Swiss TPH employs around 800 people.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

VectivBio secures investments totaling 110 million dollars
Basel Area Business & Innovation, Innovation, Invest

VectivBio secures investments totaling 110 million dollars

The Basel-based biotechnology firm VectivBio has received a capital injection of 110 million US dollars from both new and existing...

Read More
Polyphor receives up to 18 million dollars for development of antibiotics
Basel Area Business & Innovation, Innovation, Invest

Polyphor receives up to 18 million dollars for development of antibiotics

The Allschwil-based company Polyphor has received a second funding award from the global consortium CARB-X to combat antimicrobial resistance. Polyphor...

Read More
What makes Switzerland’s economy resilient in face of COVID pandemic
Basel Area Business & Innovation, Invest

What makes Switzerland’s economy resilient in face of COVID pandemic

The COVID-19 pandemic has hit economies worldwide – and we have not yet overcome it. However, Switzerland is among the...

Read More
DayOne Accelerator applications open
Basel Area Business & Innovation, Innovation

DayOne Accelerator applications open

We are excited to announce the opening of the call for the DayOne Accelerator, now in its 3rd year!

Read More
Matériaux Sabag printing concrete elements
Basel Area Business & Innovation, Innovation, Invest

Matériaux Sabag printing concrete elements

The Jura-based company Matériaux Sabag is now using a 3D printing solution to produce its concrete elements. This approach allows...

Read More
Six companies win the i4Challenge
Basel Area Business & Innovation, Innovation

Six companies win the i4Challenge

The i4Challenge expert jury has selected six winners from 18 finalists. The Industry 4.0 solutions range from 3D printing, IoT,...

Read More
Monte Rosa Therapeutics banks 96 million US dollars
Basel Area Business & Innovation, Innovation, Invest

Monte Rosa Therapeutics banks 96 million US dollars

The Basel-based biotechnology firm Monte Rosa Therapeutics has raised a total of 96 million US dollars after closing a successful...

Read More
Roche launches new coronavirus antibody test
Basel Area Business & Innovation, Innovation, Invest

Roche launches new coronavirus antibody test

Roche is launching on the market a new antibody test to determine coronavirus infections. This should help with the development...

Read More
Investors see great potential in Polyneuron
Basel Area Business & Innovation, Innovation, Invest

Investors see great potential in Polyneuron

The Basel-based company Polyneuron Pharmaceuticals extended its Series A funding round and has now raised a total of 36.5 million...

Read More
Lonza set to manufacture coronavirus drug for Humanigen
Basel Area Business & Innovation, Innovation, Invest

Lonza set to manufacture coronavirus drug for Humanigen

The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonza...

Read More
1 2 3 21

Do you have a question? We'd like to hear from you.